ALLO-316 in Patients With Advanced or Metastatic Clear Cell Renal Cell Carcinoma (ccRCC): Updated Safety and Efficacy From the Phase 1 TRAVERSE Multicenter Study Post author:andrewkaretas Post published:November 7, 2024 Post category:CD70/Scientific Publications Continue ReadingALLO-316 in Patients With Advanced or Metastatic Clear Cell Renal Cell Carcinoma (ccRCC): Updated Safety and Efficacy From the Phase 1 TRAVERSE Multicenter Study
TRAVERSE: A Phase 1 Multicenter Study Evaluating the Safety and Efficacy of ALLO-316 in Patients with Advanced or Metastatic Clear Cell Renal Cell Carcinoma (ccRCC) Post author:andrewkaretas Post published:April 6, 2023 Post category:CD70/Scientific Publications Continue ReadingTRAVERSE: A Phase 1 Multicenter Study Evaluating the Safety and Efficacy of ALLO-316 in Patients with Advanced or Metastatic Clear Cell Renal Cell Carcinoma (ccRCC)
Preclinical Development and Evaluation of Allogeneic CAR T Cells Targeting CD70 for the Treatment of Renal Cell Carcinoma Post author:andrewkaretas Post published:April 20, 2022 Post category:CD70/Scientific Publications Continue ReadingPreclinical Development and Evaluation of Allogeneic CAR T Cells Targeting CD70 for the Treatment of Renal Cell Carcinoma
Preclinical Development and Evaluation of Allogeneic CAR T Cells Targeting CD70 for the Treatment of Renal Cell Carcinoma Post author:andrewkaretas Post published:April 18, 2022 Post category:CD70/Scientific Publications Continue ReadingPreclinical Development and Evaluation of Allogeneic CAR T Cells Targeting CD70 for the Treatment of Renal Cell Carcinoma
Investigation of ALLO-316: A Fratricide-Resistant Allogeneic CAR T Targeting CD70 As a Potential Therapy for the Treatment of AML Post author:andrewkaretas Post published:December 18, 2020 Post category:CD70/Scientific Publications Continue ReadingInvestigation of ALLO-316: A Fratricide-Resistant Allogeneic CAR T Targeting CD70 As a Potential Therapy for the Treatment of AML
American Association for Cancer Research (AACR) April 2019 – AlloCAR T™ Targeting CD70 For RCC Post author:andrewkaretas Post published:April 18, 2019 Post category:CD70/Scientific Publications Continue ReadingAmerican Association for Cancer Research (AACR) April 2019 – AlloCAR T™ Targeting CD70 For RCC
